Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recurrent vulvovaginal mycoses]

J Salvat1, P Romand, A Vincent-Genod

  • 1Service de Gynécologie-Obstétrique, Centre hospitalier, Thonon.

Revue Francaise De Gynecologie Et D'Obstetrique
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secondary changes in sagittal alignment after instrumented surgery with and without corpectomy for pyogenic spondylodiscitis.

Brain & spine·2026
Same author

Incidence and management of overdrainage in pediatric hydrocephalus patients exclusively treated with modern gravitational VP shunt valves.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2026
Same author

Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 "DICIPLE" Phase III Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Prediction and risk factors for one year mortality in patients after surgery for pyogenic spondylodiscitis.

Neurosurgical review·2026
Same author

Dynamical thermal dose models and dose time-profile effects.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·2019
Same author

Surgical treatment of cerebellar hemangioblastomas.

Surgical neurology international·2017
Same journal

Endometriomas; Operative diagnosis and treatment.

Revue francaise de gynecologie et d'obstetrique·2010
Same journal

Endometriomas; Pathology and anatomy.

Revue francaise de gynecologie et d'obstetrique·2010
Same journal

Pelvic endometriosis.

Revue francaise de gynecologie et d'obstetrique·2010
Same journal

Uterine fibroid.

Revue francaise de gynecologie et d'obstetrique·2010
Same journal

Suppurative thrombophlebitis of the left utero-ovarian vein; penicillin; Surgical treatment by venous resection; healing.

Revue francaise de gynecologie et d'obstetrique·2010
Same journal

The subtotal section of the uterine body in the fibroid.

Revue francaise de gynecologie et d'obstetrique·2010
See all related articles

Recurrent vulvovaginal fungal infections are challenging to treat. Oral trifluconazole shows promise as a potent and safer alternative to ketoconazole, with fewer recurrences after treatment.

Area of Science:

  • Mycology
  • Pharmacology
  • Infectious Diseases

Context:

  • Recurrent vulvovaginal fungal infections present significant therapeutic challenges.
  • Understanding pathogenic mechanisms is crucial for effective treatment strategies.
  • Patient preference leans towards oral administration for convenience and efficacy.

Purpose:

  • To review available pharmacologic treatments for recurrent vulvovaginal fungal infections.
  • To discuss the mechanisms of action for various antifungal agents.
  • To evaluate the safety and efficacy profiles of different treatment options, particularly oral antifungals.

Summary:

  • Ketoconazole, while effective, carries significant toxicity concerns.
  • Topical or nonabsorbed oral agents are recommended for pregnant individuals.

Related Experiment Videos

  • Trifluconazole demonstrates potent antifungal activity, improved safety over ketoconazole, and reduced recurrence rates post-treatment.

    • Impact:

    • Provides a comprehensive overview of current and potential treatments for difficult-to-treat fungal infections.
    • Highlights trifluconazole as a promising agent with a favorable efficacy and safety profile.
    • Informs clinical decision-making regarding antifungal therapy, especially for recurrent cases and specific patient populations.